Injectable Drugs Market
Injectable Drugs Market: Global Industry Analysis 2014-2021 and Opportunity Assessment 2022-2032
A recent market study published by FMI on Injectable Drugs Market offers a global industry analysis for 2014-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Injectable Drugs Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Product: • Monoclonal Antibodies
• Immunoglobulin
• Cytokines
• Insulin
• Peptide Hormones
• Blood Factors
• Peptide Antibiotics
• Vaccines
• Small Molecule Antibiotics
• Chemotherapy Agents
• Others
By Application: • Oncology
• Infectious Diseases
• Diabetes
• Blood disorders
• Hormonal Disorders
• Musculoskeletal Disorders
• CNS Diseases
• Pain Management
• Cardiovascular Diseases
By Molecule Type: • Small Molecules
• Large Molecules
By Route of Administration: • Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
By Distribution Channel: • Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
By Region: • North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)
Report Chapters
Executive Summary
The executive summary of the Injectable Drugs Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Crowdsourced Security.
Chapter 01 – Market Overview
Readers can find the detailed segmentation and definition of the Injectable Drugs Market in this chapter, which will help to understand basic information about crowdsourced security. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Injectable Drugs Market report.
Chapter 02 – Market Background
This chapter includes detailed analysis of the product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 – Global Injectable Drugs Market Demand Analysis 2014-2021 and Forecast, 2022-2032
The chapter include historical market value (USD XX Mn) analysis (2015-2021) and current and future market value (US$ 531.8 Bn) and volume (5.8%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 – Global Injectable Drugs Market - Pricing Analysis
Based on By Type, the pricing analysis chapter include regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 – Global Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032, By Product
Based on By Product, Injectable Drugs Market is segmented into Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Chemotherapy Agents. This section also offers market attractiveness analysis based on By Product. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Product
Chapter 06 – Global Injectable Drugs Market Analysis 2018-2022 and Forecast 2023-2033, By Application
Based on By Application, Injectable Drugs Market is segmented into Oncology, Infectious Diseases, Diabetes, Blood disorders, Hormonal Disorders, Musculoskeletal Disorders, CNS Diseases, Pain Management, Cardiovascular Diseases. This section also offers market attractiveness analysis based on By Application. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Application.
Chapter 06 – Global Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032, By Region
Based on region, Injectable Drugs Market report covers North America, Latin America, Europe, East Asia, South Asia, Oceania, The Middle East and Africa (MEA). This section also offers market attractiveness analysis based on region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned regions.
Chapter 7 – North America Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Injectable Drugs Market in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 8 – Latin America Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the Latin America region.
Chapter 9 – Europe Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 13 – East Asia Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 14 – South Asia Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 15 - Middle East and Africa Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 16 - Key Countries Injectable Drugs Market Analysis 2015–2021 and Forecast 2022–2032
This chapter offers insights into how the Injectable Drugs Market is expected to grow in major countries globally.
Chapter 17 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 18 - Competition Deep Dive (Tentative List)
This chapter includes company overview, product portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Merck & Co., Inc., Viatris + Mylan N.V, Cipla Inc., Dr Reddy’s Laboratories Ltd., Samsung Biologics, Abbott Laboratories, Amgen Incorporated, Baxter International Incorporated, Becton Dickinson and Company, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Roche Holding Limited
Chapter 19 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Injectable Drugs Market report.
Chapter 20 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Injectable Drugs Market .
- 1. Global Market - Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supple Side Trends
- 1.4. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Definition and Introduction
- 2.2. Market Taxonomy/ Research Scope
- 2.3. Inclusions & Exclusions
- 3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Product Innovation / Development Trends
- 4. Key Success Factors
- 4.1. Disease Epidemiology
- 4.2. Pipeline Analysis
- 4.3. Regulatory Scenario
- 4.4. Promotional Strategies, By Key Manufacturers
- 4.5. Supply chain Analysis
- 4.6. PESTEL Analysis
- 4.7. PORTER Analysis
- 4.8. Number of Clinical Trial
- 4.9. List of Manufacturers
- 5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Rising per-Capita Healthcare Expenditure
- 5.1.3. Generic Versions Intensify Total Sale
- 5.1.4. Plant Upgrades Pushing Pricing of Injectable Drugs
- 5.1.5. Favorable Reimbursement Scenario Fuels the Market Growth
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Product Cost
- 5.2.2. Frequency of Product Lunches
- 5.2.3. Per Patient Spending
- 5.2.4. Product Awareness
- 5.2.5. Products in Pipeline
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
- 6. COVID19 Crisis Analysis
- 6.1. Current COVID19 Statistics and Probable Future Impact
- 6.2. Current GDP Projection and Probable Impact
- 6.3. Current Economic Projection as compared to 2008 financial analysis
- 6.4. COVID19 and Impact Analysis
- 6.4.1. Revenue By Product
- 6.4.2. Revenue By Application
- 6.4.3. Revenue By Molecule
- 6.4.4. Revenue By Route of Administration
- 6.4.5. Revenue By Distribution Channel
- 6.5. 2020 Market Scenario
- 7. Global Market Value (US$ Bn) Analysis 2014-2021 and Forecast, 2022-2032
- 7.1. Historical Market Value (US$ Bn) Analysis, 2014-2021
- 7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
- 8. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Product
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Bn) Analysis By Product , 2014-2021
- 8.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Product, 2022-2032
- 8.3.1. Monoclonal Antibodies
- 8.3.2. Immunoglobulin
- 8.3.3. Cytokines
- 8.3.4. Insulin
- 8.3.5. Peptide Hormones
- 8.3.6. Blood Factors
- 8.3.7. Peptide Antibiotics
- 8.3.8. Vaccines
- 8.3.9. Small Molecule Antibiotics
- 8.3.10. Chemotherapy Agents
- 8.3.11. Others
- 8.4. Market Attractiveness Analysis By Product
- 9. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Application
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Bn) Analysis By Application , 2014-2021
- 9.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Application , 2022-2032
- 9.3.1.1. Oncology
- 9.3.1.2. Infectious Diseases
- 9.3.1.3. Diabetes
- 9.3.1.4. Blood disorders
- 9.3.1.5. Hormonal Disorders
- 9.3.1.6. Musculoskeletal Disorders
- 9.3.1.7. CNS Diseases
- 9.3.1.8. Pain Management
- 9.3.1.9. Cardiovascular Diseases
- 9.4. Market Attractiveness Analysis By Application
- 10. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Molecule Type
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Bn) Analysis By Molecule Type, 2014-2021
- 10.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Molecule Type, 2022-2032
- 10.3.1.1. Small Molecule
- 10.3.1.2. Large Molecule
- 10.4. Market Attractiveness Analysis By Distribution Channel
- 11. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Route of Administration
- 11.1. Introduction / Key Findings
- 11.2. Historical Market Size (US$ Bn) Analysis By Route of Administration, 2014-2021
- 11.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Route of Administration, 2022-2032
- 11.3.1.1. Intravenous
- 11.3.1.2. Intramuscular
- 11.3.1.3. Subcutaneous
- 11.4. Market Attractiveness Analysis By Route of Administration
- 12. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Distribution Channel
- 12.1. Introduction / Key Findings
- 12.2. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2014-2021
- 12.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Distribution Channel, 2022-2032
- 12.3.1.1. Hospital Pharmacies
- 12.3.1.2. Retail Pharmacies
- 12.3.1.3. Drug Stores
- 12.3.1.4. Online Pharmacies
- 12.4. Market Attractiveness Analysis By Distribution Channel
- 13. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Region
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Bn) Analysis By Region, 2014-2021
- 13.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Region, 2022-2032
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. South Asia
- 13.3.5. East Asia
- 13.3.6. Oceania
- 13.3.7. Middle East & Africa
- 13.4. Market Attractiveness Analysis By Region
- 14. North America Market Analysis 2014-2021 and Forecast 2022-2032
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
- 14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
- 14.3.1. By Country
- 14.3.1.1. US
- 14.3.1.2. Canada
- 14.3.2. By Product
- 14.3.3. By Application
- 14.3.4. By Molecule Type
- 14.3.5. Route of administration
- 14.3.6. By Distribution Channel
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Product
- 14.4.2. By Application
- 14.4.3. By Molecule Type
- 14.4.4. Route of administration
- 14.4.5. By Distribution Channel
- 14.5. Key Market Participants - Intensity Mapping
- 14.6. Drivers and Restraints - Impact Analysis
- 14.7. Country Level Analysis & Forecast
- 14.7.1. U.S. Market
- 14.7.1.1. Introduction
- 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.7.1.2.1. By Product
- 14.7.1.2.2. By Application
- 14.7.1.2.3. By Molecule Type
- 14.7.1.2.4. Route of administration
- 14.7.1.2.5. By Distribution Channel
- 14.7.2. Canada Market
- 14.7.2.1. Introduction
- 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.7.2.2.1. By Product
- 14.7.2.2.2. By Application
- 14.7.2.2.3. By Molecule Type
- 14.7.2.2.4. Route of administration
- 14.7.2.2.5. By Distribution Channel
- 15. Latin America Market Analysis 2014-2021 and Forecast 2022-2032
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
- 15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
- 15.3.1. By Country
- 15.3.1.1. Brazil
- 15.3.1.2. Mexico
- 15.3.1.3. Argentina
- 15.3.1.4. Rest of Latin America
- 15.3.2. By Product
- 15.3.3. By Application
- 15.3.4. By Molecule Type
- 15.3.5. Route of administration
- 15.3.6. By Distribution Channel
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Product
- 15.4.2. By Application
- 15.4.3. By Molecule Type
- 15.4.4. Route of administration
- 15.4.5. By Distribution Channel
- 15.5. Key Market Participants - Intensity Mapping
- 15.6. Drivers and Restraints - Impact Analysis
- 15.7. Country Level Analysis & Forecast
- 15.7.1. Brazil Market
- 15.7.1.1. Introduction
- 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.7.1.2.1. By Product
- 15.7.1.2.2. By D By Application
- 15.7.1.2.3. By Molecule Type
- 15.7.1.2.4. Route of administration distribution Channel
- 15.7.2. Argentina Market
- 15.7.2.1. Introduction
- 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.7.2.2.1. By Product
- 15.7.2.2.2. By Application
- 15.7.2.2.3. By Molecule Type
- 15.7.2.2.4. Route of administration
- 15.7.2.2.5. Distribution Channel
- 15.7.3. Mexico Market
- 15.7.3.1. Introduction
- 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.7.3.2.1. By Product
- 15.7.3.2.2. B By Application
- 15.7.3.2.3. By Molecule Type
- 15.7.3.2.4. Route of administration
- 15.7.3.2.5. Distribution Channel
- 16. Europe Market Analysis 2014-2021 and Forecast 2022-2032
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
- 16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
- 16.3.1. By Country
- 16.3.1.1. Germany
- 16.3.1.2. Italy
- 16.3.1.3. France
- 16.3.1.4. U.K.
- 16.3.1.5. Spain
- 16.3.1.6. BENELUX
- 16.3.1.7. Russia
- 16.3.1.8. Rest of Europe
- 16.3.1.8.1. By Product
- 16.3.1.8.2. By Application
- 16.3.1.8.3. By Molecule Type
- 16.3.1.8.4. Route of administration
- 16.3.1.8.5. By Distribution Channel
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Product
- 16.4.2. By Application
- 16.4.3. By Molecule Type
- 16.4.4. Route of administration
- 16.4.5. By Distribution Channel
- 16.5. Country Level Analysis & Forecast
- 16.5.1. Germany Market
- 16.5.1.1. Introduction
- 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.1.2.1. By Product
- 16.5.1.2.2. By Application
- 16.5.1.2.3. By Molecule Type
- 16.5.1.2.4. Route of administration
- 16.5.1.2.5. By Distribution Channel
- 16.5.2. Italy Market
- 16.5.2.1. Introduction
- 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.2.2.1. By Product
- 16.5.2.2.2. By Application
- 16.5.2.2.3. By Molecule Type
- 16.5.2.2.4. Route of administration
- 16.5.2.2.5. By Distribution Channel
- 16.5.3. France Market
- 16.5.3.1. Introduction
- 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.3.2.1. By Product
- 16.5.3.2.2. By Application
- 16.5.3.2.3. By Molecule Type
- 16.5.3.2.4. Route of administration
- 16.5.3.2.5. By Distribution Channel
- 16.5.4. U.K. Injectable Drugs Market
- 16.5.4.1. Introduction
- 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.4.2.1. By Product
- 16.5.4.2.2. By Application
- 16.5.4.2.3. By Molecule Type
- 16.5.4.2.4. Route of administration
- 16.5.4.2.5. By Distribution Channel
- 16.5.5. Spain Market
- 16.5.5.1. Introduction
- 16.5.5.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.5.3. By Product
- 16.5.5.4. By Application
- 16.5.5.5. By Molecule Type
- 16.5.5.6. Route of administration
- 16.5.5.7. By Distribution Channel
- 16.5.6. BENELUX Market
- 16.5.6.1. Introduction
- 16.5.6.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.6.2.1. By Product
- 16.5.6.2.2. By Application
- 16.5.6.2.3. By Molecule Type
- 16.5.6.2.4. Route of administration
- 16.5.6.2.5. By Distribution Channel
- 16.5.7. Russia Market
- 16.5.7.1. Introduction
- 16.5.7.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.7.2.1. By Product
- 16.5.7.2.2. By Application
- 16.5.7.2.3. By Molecule Type
- 16.5.7.2.4. Route of administration
- 16.5.7.2.5. By Distribution Channel
- 17. South Asia Market Analysis 2014-2021 and Forecast 2022-2032
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
- 17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
- 17.3.1. By Country
- 17.3.1.1. India
- 17.3.1.2. Thailand
- 17.3.1.3. Malaysia
- 17.3.1.4. Rest Of South Asia
- 17.3.1.4.1. By Product
- 17.3.1.4.2. By Application
- 17.3.1.4.3. By Molecule Type
- 17.3.1.4.4. Route of administration
- 17.3.1.4.5. By Distribution Channel
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Application
- 17.4.4. By Molecule Type
- 17.4.5. Route of administration
- 17.4.6. By Distribution Channel
- 17.5. Country Level Analysis & Forecast
- 17.5.1. India Market
- 17.5.1.1. Introduction
- 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.1.2.1. By Product
- 17.5.1.2.2. By Application
- 17.5.1.2.3. By Molecule Type
- 17.5.1.2.4. Route of administration
- 17.5.1.2.5. By Distribution Channel
- 17.5.2. Thailand Market
- 17.5.2.1. Introduction
- 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.2.2.1. By Product
- 17.5.2.2.2. By Application
- 17.5.2.2.3. By Molecule Type
- 17.5.2.2.4. Route of administration
- 17.5.2.2.5. By Distribution Channel
- 17.5.3. Malaysia Market
- 17.5.3.1. Introduction
- 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.3.2.1. By Product
- 17.5.3.2.2. By Application
- 17.5.3.2.3. By Molecule Type
- 17.5.3.2.4. Route of administration
- 17.5.3.2.5. By Distribution Channel
- 18. East Asia Market Analysis 2014-2021 and Forecast 2022-2032
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
- 18.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
- 18.3.1. By Country
- 18.3.1.1. China
- 18.3.1.2. Japan
- 18.3.1.3. South Korea
- 18.3.1.3.1. By Product
- 18.3.1.3.2. By Application
- 18.3.1.3.3. By Molecule Type
- 18.3.1.3.4. Route of administration
- 18.3.1.3.5. By Distribution Channel
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Application
- 18.4.4. By Molecule Type
- 18.4.5. Route of administration
- 18.4.6. By Distribution Channel
- 18.5. Country Level Analysis & Forecast
- 18.5.1. China Market
- 18.5.1.1. Introduction
- 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.1.2.1. By Product
- 18.5.1.2.2. By Application
- 18.5.1.2.3. By Molecule Type
- 18.5.1.2.4. Route of administration
- 18.5.1.2.5. By Distribution Channel
- 18.5.2. Japan Market
- 18.5.2.1. Introduction
- 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.2.2.1. By Product
- 18.5.2.2.2. By Application
- 18.5.2.2.3. By Molecule Type
- 18.5.2.2.4. Route of administration
- 18.5.2.2.5. By Distribution Channel
- 18.5.3. South Korea Market
- 18.5.3.1. Introduction
- 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.3.2.1. By Product
- 18.5.3.2.2. By Application
- 18.5.3.2.3. By Molecule Type
- 18.5.3.2.4. Route of administration
- 18.5.3.2.5. By Distribution Channel
- 19. Oceania Market Analysis 2014-2021 and Forecast 2022-2032
- 19.1. Introduction
- 19.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2014-2021
- 19.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
- 19.3.1. By Country
- 19.3.1.1. Australia
- 19.3.1.2. New Zealand
- 19.3.1.2.1. By Product
- 19.3.1.2.2. By Application
- 19.3.1.2.3. By Molecule Type
- 19.3.1.2.4. Route of administration
- 19.3.1.2.5. By Distribution Channel
- 19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Application
- 19.4.4. By Molecule Type
- 19.4.5. Route of administration
- 19.4.6. By Distribution Channel
- 19.5. Country Level Analysis & Forecast
- 19.5.1. Australia Market
- 19.5.1.1. Introduction
- 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.1.2.1. By Product
- 19.5.1.2.2. By Application
- 19.5.1.2.3. By Molecule Type
- 19.5.1.2.4. Route of administration
- 19.5.1.2.5. By Distribution Channel
- 19.5.2. New Zealand Market
- 19.5.2.1. Introduction
- 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.2.2.1. By Product
- 19.5.2.2.2. By Application
- 19.5.2.2.3. By Molecule Type
- 19.5.2.2.4. Route of administration
- 19.5.2.2.5. By Distribution Channel
- 20. MEA Market Analysis 2014-2021 and Forecast 2022-2032
- 20.1. Introduction
- 20.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2014-2021
- 20.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
- 20.3.1. By Country
- 20.3.1.1. GCC Countries
- 20.3.1.2. South Africa
- 20.3.1.3. Rest of MEA
- 20.3.1.3.1. By Product
- 20.3.1.3.2. By Application
- 20.3.1.3.3. By Molecule Type
- 20.3.1.3.4. Route of administration
- 20.3.1.3.5. By Distribution Channel
- 20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Product
- 20.4.3. By Distribution Channel
- 20.5. Country Level Analysis & Forecast
- 20.5.1. GCC Countries Global Market
- 20.5.1.1. Introduction
- 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 20.5.1.2.1. By Product
- 20.5.1.2.2. By Application
- 20.5.1.2.3. By Molecule Type
- 20.5.1.2.4. Route of administration
- 20.5.1.2.5. By Distribution Channel
- 20.5.2. South Africa Countries Market
- 20.5.2.1. Introduction
- 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 20.5.2.2.1. By Product
- 20.5.2.2.2. By Application
- 20.5.2.2.3. By Molecule Type
- 20.5.2.2.4. Route of administration
- 20.5.2.2.5. By Distribution Channel
- 21. Market Structure Analysis
- 21.1. Market Analysis by Tier of Companies (Global Injectable Drugs)
- 21.2. Market Concentration
- 21.3. Market Share Analysis of Top Players
- 21.4. Market Presence Analysis
- 22. Competition Analysis
- 22.1. Competition Dashboard
- 22.2. Competition Benchmarking
- 22.3. Competition Deep Dive
- 22.3.1.1. Novartis
- 22.3.1.1.1. Overview
- 22.3.1.1.2. Product Portfolio
- 22.3.1.1.3. Recent Developments
- 22.3.1.1.4. Regional Footprint
- 22.3.1.1.5. Strategy Overview
- 22.3.1.1.6. SWOT Analysis
- 22.3.1.2. Pfizer Inc.,
- 22.3.1.2.1. Overview
- 22.3.1.2.2. Product Portfolio
- 22.3.1.2.3. Recent Developments
- 22.3.1.2.4. Regional Footprint
- 22.3.1.2.5. Strategy Overview
- 22.3.1.2.6. SWOT Analysis
- 22.3.1.3. Teva Pharmaceutical Industries Ltd.
- 22.3.1.3.1. Overview
- 22.3.1.3.2. Product Portfolio
- 22.3.1.3.3. Recent Developments
- 22.3.1.3.4. Regional Footprint
- 22.3.1.3.5. Strategy Overview
- 22.3.1.3.6. SWOT Analysis
- 22.3.1.4. Sanofi S.A.
- 22.3.1.4.1. Overview
- 22.3.1.4.2. Product Portfolio
- 22.3.1.4.3. Recent Developments
- 22.3.1.4.4. Regional Footprint
- 22.3.1.4.5. Strategy Overview
- 22.3.1.4.6. SWOT Analysis
- 22.3.1.5. Sun Pharmaceutical Industries Ltd.
- 22.3.1.5.1. Overview
- 22.3.1.5.2. Product Portfolio
- 22.3.1.5.3. Recent Developments
- 22.3.1.5.4. Regional Footprint
- 22.3.1.5.5. Strategy Overview
- 22.3.1.5.6. SWOT Analysis
- 22.3.1.6. AstraZeneca Plc
- 22.3.1.6.1. Overview
- 22.3.1.6.2. Product Portfolio
- 22.3.1.6.3. Recent Developments
- 22.3.1.6.4. Regional Footprint
- 22.3.1.6.5. Strategy Overview
- 22.3.1.6.6. SWOT Analysis
- 22.3.1.7. Merck & Co., Inc.
- 22.3.1.7.1. Overview
- 22.3.1.7.2. Product Portfolio
- 22.3.1.7.3. Recent Developments
- 22.3.1.7.4. Regional Footprint
- 22.3.1.7.5. Strategy Overview
- 22.3.1.7.6. SWOT Analysis
- 22.3.1.8. Viatris + Mylan N.V
- 22.3.1.8.1. Overview
- 22.3.1.8.2. Product Portfolio
- 22.3.1.8.3. Recent Developments
- 22.3.1.8.4. Regional Footprint
- 22.3.1.8.5. Strategy Overview
- 22.3.1.8.6. SWOT Analysis
- 22.3.1.9. Cipla Inc.
- 22.3.1.9.1. Overview
- 22.3.1.9.2. Product Portfolio
- 22.3.1.9.3. Recent Developments
- 22.3.1.9.4. Regional Footprint
- 22.3.1.9.5. Strategy Overview
- 22.3.1.9.6. SWOT Analysis
- 22.3.1.10. Dr. Reddy’s Laboratories Ltd.
- 22.3.1.10.1. Overview
- 22.3.1.10.2. Product Portfolio
- 22.3.1.10.3. Recent Developments
- 22.3.1.10.4. Regional Footprint
- 22.3.1.10.5. Strategy Overview
- 22.3.1.10.6. SWOT Analysis
- 22.3.1.11. Samsung Biologics
- 22.3.1.11.1. Overview
- 22.3.1.11.2. Product Portfolio
- 22.3.1.11.3. Recent Developments
- 22.3.1.11.4. Regional Footprint
- 22.3.1.11.5. Strategy Overview
- 22.3.1.11.6. SWOT Analysis
- 22.3.1.12. Abbott Laboratories
- 22.3.1.12.1. Overview
- 22.3.1.12.2. Product Portfolio
- 22.3.1.12.3. Recent Developments
- 22.3.1.12.4. Regional Footprint
- 22.3.1.12.5. Strategy Overview
- 22.3.1.12.6. SWOT Analysis
- 22.3.1.13. Amgen Incorporated
- 22.3.1.13.1. Overview
- 22.3.1.13.2. Product Portfolio
- 22.3.1.13.3. Recent Developments
- 22.3.1.13.4. Regional Footprint
- 22.3.1.13.5. Strategy Overview
- 22.3.1.13.6. SWOT Analysis
- 22.3.1.14. Baxter International Incorporated
- 22.3.1.14.1. Overview
- 22.3.1.14.2. Product Portfolio
- 22.3.1.14.3. Recent Developments
- 22.3.1.14.4. Regional Footprint
- 22.3.1.14.5. Strategy Overview
- 22.3.1.14.6. SWOT Analysis
- 22.3.1.15. Becton, Dickinson and Company
- 22.3.1.15.1. Overview
- 22.3.1.15.2. Product Portfolio
- 22.3.1.15.3. Recent Developments
- 22.3.1.15.4. Regional Footprint
- 22.3.1.15.5. Strategy Overview
- 22.3.1.15.6. SWOT Analysis
- 22.3.1.16. Bristol-Myers Squibb Company
- 22.3.1.16.1. Overview
- 22.3.1.16.2. Product Portfolio
- 22.3.1.16.3. Recent Developments
- 22.3.1.16.4. Regional Footprint
- 22.3.1.16.5. Strategy Overview
- 22.3.1.16.6. SWOT Analysis
- 22.3.1.17. GlaxoSmithKline Plc
- 22.3.1.17.1. Overview
- 22.3.1.17.2. Product Portfolio
- 22.3.1.17.3. Recent Developments
- 22.3.1.17.4. Regional Footprint
- 22.3.1.17.5. Strategy Overview
- 22.3.1.17.6. SWOT Analysis
- 22.3.1.18. Roche Holding Limited.
- 22.3.1.18.1. Overview
- 22.3.1.18.2. Product Portfolio
- 22.3.1.18.3. Recent Developments
- 22.3.1.18.4. Regional Footprint
- 22.3.1.18.5. Strategy Overview
- 22.3.1.18.6. SWOT Analysis
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook